ClinConnect ClinConnect Logo
Search / Trial NCT06729762

Ultrasound-guided Thermal Ablation for Benign Thyroid Nodules

Launched by CHINESE PLA GENERAL HOSPITAL · Dec 7, 2024

Trial Information

Current as of September 10, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a treatment called ultrasound-guided thermal ablation for people with benign thyroid nodules, which are non-cancerous lumps in the thyroid gland. The goal is to see how effective this treatment is over the long term, especially for those who have concerns about their nodules causing cosmetic or symptom issues, or who may not be eligible or willing to have surgery.

To participate in this trial, individuals need to have confirmation from two separate tests that their nodules are benign, and they should not show any signs of cancer on ultrasound. Participants must also be at least 65 years old and have a follow-up period of at least 12 months. Throughout the trial, participants can expect regular check-ups to monitor their condition and see how well the treatment works. This trial is currently recruiting participants of all genders who meet the eligibility criteria.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. confirmation of benign nodule status on two separate fine- needle aspiration or core-needle biopsy
  • 2. no suspicious malignant features on ultrasound examination
  • 3. report of cosmetic and/ or symptomatic problems or concern of nodules growing rapidly or malignant transformation
  • 4. refusal or ineligibility for surgery
  • 5. follow-up time ≥12 months
  • Exclusion Criteria:
  • 1. follicular neoplasm or malignancy findings on biopsy
  • 2. nodules with benign result on biopsy had suspicious of malignancy in US
  • 3. patients with contra-lateral vocal cord paralysis
  • 4. previous radiation to the head and neck
  • 5. follow- up time less than 12 months

About Chinese Pla General Hospital

The Chinese PLA General Hospital, a prominent military medical institution in Beijing, serves as a leading sponsor for clinical trials, focusing on advancing healthcare through innovative research and development. Renowned for its comprehensive medical services and cutting-edge research capabilities, the hospital is committed to improving patient outcomes through rigorous scientific investigation and collaboration with various stakeholders in the healthcare sector. With a multidisciplinary approach and a strong emphasis on evidence-based practices, the Chinese PLA General Hospital aims to contribute significantly to the global medical community by facilitating the development of safe and effective therapeutic interventions.

Locations

Beijing, Beijing, China

Patients applied

0 patients applied

Trial Officials

Yukun Luo

Principal Investigator

Chinese PLA General Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported